IMMUNE AMERICA INC
8-K, 1996-09-26
BLANK CHECKS
Previous: WASATCH INTERNATIONAL CORP, 10KSB, 1996-09-26
Next: LARSON DAVIS INC, NT 10-K, 1996-09-26










                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    Form 8-K

                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



  Date of Report (Date of earliest event reported): August 15, 1996.



                              Immune America, Inc.
             (Exact name of registrant as specified in its charter)


       NEVADA                    33-10281                      75-2641513
(State or Other 
Jurisdiction                (Commission File No.)           (I.R.S. Employer
of incorporation                                            Identification No.)
 or organization)                                                           



              12342 Roscoe Boulevard, Sun Valley, California 91352
               (Address of principal executive offices, zip code)



       Registrant's telephone number, including area code: (818) 767-5863









<PAGE>



                           Current Report on Form 8-K

                              Immune America, Inc.


Item 1.  Changes in Control of Registrant.

         On August  15,  1996,  there  occurred  a change in  control  of Immune
America,  Inc.,  a  Nevada  corporation  (the  "Company").  Little  and  Company
Investment  Securities,  a Texas  Corporation  ("LCIS"),  a company owned by Mr.
Glenn A. Little, purchased, from the Company, 15,000,000 shares of the Company's
Common Stock for $15,000 in cash, pursuant to a Subscription Agreement. The cash
utilized by LCIS to acquire such shares came from LCIS's working capital and not
from  the  proceeds  of a  loan  or  other  arrangement.  As a  result  of  such
transaction,  LCIS owns  51.69% of the  currently  outstanding  shares of Common
Stock of the Company.  There is no existing arrangement or understanding between
LCIS, or any of its affiliates, and the Company, or any of its affiliates,  with
respect to the election of directors or any other matter.  LCIS has indicated to
the  Company  that it does  not  expect  to  effect a  change  in the  Company's
management for the foreseeable future.

                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto, duly authorized.

                              IMMUNE AMERICA, INC.



Dated: September 16, 1996                      By: /s/ Elizabeth Huntley
                                                   ---------------------
                                                   Dr. Elizabeth Huntley
                                                   President




<PAGE>



                                INDEX TO EXHIBITS


                       Exhibit No. Description of Exhibit

   10.1          Subscription Agreement between Registrant and
                 Little and Company Investment Securities, dated
                 August 15, 1996



<PAGE>



                                  Exhibit 10.1


<PAGE>













                             SUBSCRIPTION AGREEMENT



                            SALE OF 15,000,000 SHARES
                               OF COMMON STOCK OF
                              IMMUNE AMERICA, INC.




















                              Immune America, Inc.
                             12342 Roscoe Boulevard
                          Sun Valley, California 91352







<PAGE>



SUBSCRIPTION AGREEMENT





Immune America, Inc.
12342 Roscoe Boulevard
Sun Valley, California 91352



Ladies and Gentlemen:

1.  Subscription.  The undersigned,  Little and Company  Investment  Securities,
hereby  subscribe  for and agree to purchase  15,000,000  shares of Common Stock
(the "Shares") of Immune America, Inc. (the "Company"), at a price equivalent to
$0.001 per share for a total sum of $15,000.  Simultaneously  with the execution
of this Subscription  Agreement,  the undersigned are submitting  payment of the
purchase  price in the amounts set forth on the  signature  pages below,  in the
form of a check (the "Payment") payable to Immune America, Inc..

2. Acceptance of Subscription.  The undersigned acknowledge that the Company has
the right to accept or reject this  subscription,  in whole or in part, and that
this Subscription  shall be deemed to be accepted by the Company only when it is
signed by the Company.

3.  Representations,   Warranties,   and  Covenants  of  the  Undersigned.   The
undersigned  hereby represent and warrant to and covenant with the Company,  its
agents and employees as follows:

(a) The  undersigned  understand  that sale of the Shares to the undersigned are
being made by the Company  pursuant to Sections 3(b) and 4(2) of the  Securities
Act of 1933, as amended (the "Securities  Act") and/or  Regulation D promulgated
thereunder and applicable state securities laws. The undersigned understand that
the Shares will not be registered  under the Securities Act in reliance upon the
exemptions  from  registration  provided  by  Sections  3(b)  and  4(2)  of  the
Securities Act and/or Regulation D.

(b) The undersigned have adequate means of providing for their current needs and
possible personal  contingencies,  and they have no need, and anticipate no need
in the foreseeable  future,  to sell the Shares for which they hereby subscribe.
They are able to bear the economic risks of this investment  and,  consequently,
without  limiting the  generality  of the  foregoing,  they are able to hold the
Shares for an indefinite period of time and have sufficient net worth to sustain
a loss of their entire investment in the Company if such loss should occur.


(c) The undersigned have such knowledge and experience in financial and business
matters  that  they  are  capable  of  evaluating  the  merits  and  risks of an
investment in the Company.


(d) The undersigned confirm that all documents,  records and books pertaining to
this proposed investment in the Company have been made available to them.


(e) The  undersigned  have had an  opportunity  to ask  questions of and receive
satisfactory  answers from the Company,  or any person or persons  acting on the
Company's  behalf,  concerning the terms and conditions of this investment,  and
all  such  questions  have  been  answered  to  the  full  satisfaction  of  the
undersigned





<PAGE>



Page 2.




(f) The Shares for which the undersigned  hereby  subscribe will be acquired for
their  own  account  for  investment  and not  with the view  toward  resale  or
redistribution in a manner which would require registration under the Securities
Act. .

(g) The  undersigned  represent  that it has been called to their  attention  by
those  individuals with whom they have dealt in connection with their investment
in the Company,  that their  investment in the Company involves a high degree of
risk which may result in the loss of the total amount of their investment.


(h) The  undersigned  are not  subscribing  for the  Shares  as a  result  of or
subsequent  to  any  advertisement,   article,  notice  or  other  communication
published  in any  newspaper,  magazine  or similar  media,  or  broadcast  over
television or radio, or presented at any seminar or meeting or any  solicitation
of a  subscription  by a  person  not  previously  known to the  undersigned  in
connection with investments in securities generally.


(I) The  undersigned  are now bona fide residents of the state set forth in this
Subscription Agreement and the address and social security number or federal tax
identification  number set forth in this  Subscription  Agreement are their true
and correct residence and social security numbers or federal tax  identification
numbers. The undersigned have no present intention of becoming a resident of any
other state or jurisdiction.  If the undersigned is a corporation,  partnership,
trust or other form of business organization, it represents and warrants that it
was formed  under the laws of, and its  principal  place of  business is within,
such  state,  and that it was not  organized  for the purpose of  acquiring  the
Shares.


(j) The undersigned represent that they have made other investments of a similar
nature  and,  by reason  of their  business  and  financial  experience  and the
business and financial  experience of those persons they have retained to advise
them with respect to their investment in the Company, have acquired the capacity
to protect  their own interest in  investments  of this nature.  In reaching the
conclusion  that  they  desire to  acquire  the  Shares,  the  undersigned  have
carefully  evaluated their financial  resources and investment  position and the
risks associated with this investment and acknowledge that they are able to bear
the economic risks of the investment.


4. Limitations on Transfer of the Shares. The undersigned  acknowledge that they
are aware that there are substantial  restrictions on the transferability of the
Shares.  Since  the  Shares  will not be,  and the  undersigned  has no right to
require that they be registered under the Securities Act or any applicable state
securities  laws,  the Shares may not be,  and the  undersigned  agree that they
shall not be, sold unless the Shares are registered  under the Securities Act or
such sale is exempt  from such  registration  under the  Securities  Act and any
other applicable state securities laws or regulations.  The undersigned  further
acknowledge that the Company is under no obligation to aid them in obtaining any
exemption from such registration requirements.  The undersigned also acknowledge
that they shall be responsible  for  compliance  with all conditions on transfer
imposed  by any  securities  administrator  of any  state  and for any  expenses
incurred by the  Company for legal or  accounting  services in  connection  with
reviewing  such a  proposed  transfer  and/or  issuing  opinions  in  connection
therewith.


5. Compliance with Securities Laws. The undersigned  agree that the Shares shall
not be sold,  pledged,  hypothecated or otherwise  transferred unless the Shares
are registered  under the Securities Act and applicable state securities laws or
are exempt therefrom.






<PAGE>



Page 3


                           CORPORATION SIGNATURE PAGE


   Execution of this Signature Page constitutes execution of the Subscription
   Agreement.

        I  .  The  undersigned   CORPORATION  hereby  certifies  that  its  duly
        authorized officer has read and understands the Subscription  Agreement,
        and the  representations  and warranties herein are accurate on the date
        hereof.


        2. The undersigned  CORPORATION  hereby represents and warrants that the
        officer(s)  executing  the  Subscription  Agreement  on  behalf  of  the
        undersigned  CORPORATION has (have) been duly authorized by the terms of
        the CORPORATION instrument of the undersigned CORPORATION to acquire the
        Shares  and  execute  the  Subscription   Agreement  on  behalf  of  the
        undersigned CORPORATION,  and, further, that the undersigned CORPORATION
        has all  requisite  authority  to acquire such Shares and enter into the
        Subscription Agreement.


IN WITNESS WHEREOF,  the undersigned  CORPORATION has caused its duly authorized
officer to execute this Subscription Agreement.


Number of Shares subscribed                                   15,000,000

Investment in the Company
(Number of  Shares x $0.001 for each Share purchased)            $15,000

Little and Company Investment Securities, a Texas Corporation
The Little and Company Building
211 West Wall
Midland, Texas 79701                      Tax identification number: 75-1682844
                                          -------------------------------------




________/s/____________________________

Glenn A. Little, President


ACCEPTED BY:
Immune America, Inc.




__________/s/__________________________

Dr. Elizabeth Huntley
President





<PAGE>



                              IMMUNE AMERICA, INC.
                     UNANIMOUS CONSENT OF BOARD OF DIRECTORS
                           IN LIEU OF SPECIAL MEETING




The  undersigned,  being all the  members  of the Board of  Directors  of Immune
America, Inc. ("Company"), a Nevada corporation, do hereby consent that when all
the Directors  have signed this Consent,  or an exact  counterpart  hereof,  the
Resolutions  hereinafter  set forth shall be deemed to have been  adopted to the
same  extent  and shall have the same force and effect as if adopted at a formal
special  meeting of the  Directors of the Company,  duly called and held for the
purposes of acting upon proposals to adopt the following Resolutions:

WHEREAS,  the  Company  has  received  subscriptions  from  Little  and  Company
Investment  Securities to purchase  15,000,000  shares of the  Company's  Common
Stock, for $15,000. or approximately $.001 per share;

WHEREAS,  the  Board  of  Directors  is of the  opinion  that it is in the  best
interest  of the  Company to accept  the above  described  subscriptions  and to
consummate  the sale of 15,000,000  shares of the Company's  Common Stock for an
aggregate of $15,000;

NOW, THEREFORE,  BE IT RESOLVED, that the offers of the aforesaid subscribers to
purchase the number of shares of Common  Stock as set forth above,  be, and they
are hereby, accepted and approved;

RESOLVED FURTHER,  that the Chief Executive Officer,  President and Secretary of
the Company be, and they are hereby,  authorized  and empowered to issue to each
of the  aforementioned  subscribers  a  stock  certificate  in the  name  of the
subscriber  with the  corresponding  number of shares of the Common Stock of the
Company as purchased by said subscriber;

RESOLVED FURTHER,  that the Chief Executive Officer,  President and Secretary of
the Company be, and they are hereby,  authorized,  empowered and directed to do,
undertake  and  perform any and all actions or acts  necessary,  appropriate  or
advisable  to  accomplish  and  effectuate  the  intents  and  purposes of these
resolutions, including without limitation, receiving the aforesaid consideration
and the issuance and delivery of certificates  evidencing the aforesaid sales of
the shares of the Company's Common Stock.


Board of Directors:





___________/s/______________                  ___________/s/___________________
Dr. Elizabeth Huntley                         Michael R. Moore








<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission